[go: up one dir, main page]

MX2019000977A - Composiciones farmacéuticas a base de curcumina y procedimientos para su fabricación. - Google Patents

Composiciones farmacéuticas a base de curcumina y procedimientos para su fabricación.

Info

Publication number
MX2019000977A
MX2019000977A MX2019000977A MX2019000977A MX2019000977A MX 2019000977 A MX2019000977 A MX 2019000977A MX 2019000977 A MX2019000977 A MX 2019000977A MX 2019000977 A MX2019000977 A MX 2019000977A MX 2019000977 A MX2019000977 A MX 2019000977A
Authority
MX
Mexico
Prior art keywords
curcumin
fabricating
methods
pharmaceutical compositions
based pharmaceutical
Prior art date
Application number
MX2019000977A
Other languages
English (en)
Inventor
Elias Saadeh Dennis
IBRAHIM Nadia
Original Assignee
Harrow Health Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Harrow Health Inc filed Critical Harrow Health Inc
Publication of MX2019000977A publication Critical patent/MX2019000977A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/12—Ketones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/906—Zingiberaceae (Ginger family)
    • A61K36/9066—Curcuma, e.g. common turmeric, East Indian arrowroot or mango ginger
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/40—Cyclodextrins; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Engineering & Computer Science (AREA)
  • Inorganic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Dispersion Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Dermatology (AREA)
  • Biophysics (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)

Abstract

Se describen composiciones farmacéuticas, las composiciones consisten esencialmente en emulsiones acuosas de una cantidad terapéuticamente eficaz de un compuesto diarilheptanoide (tal como curcumina). También se describen procedimientos para fabricar las composiciones y para usarlas.
MX2019000977A 2016-07-26 2017-07-19 Composiciones farmacéuticas a base de curcumina y procedimientos para su fabricación. MX2019000977A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201662366807P 2016-07-26 2016-07-26
PCT/US2017/042818 WO2018022378A1 (en) 2016-07-26 2017-07-19 Curcumin-based pharmaceutical compositions and methods for fabricating thereof

Publications (1)

Publication Number Publication Date
MX2019000977A true MX2019000977A (es) 2019-08-01

Family

ID=61012353

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2019000977A MX2019000977A (es) 2016-07-26 2017-07-19 Composiciones farmacéuticas a base de curcumina y procedimientos para su fabricación.

Country Status (8)

Country Link
US (1) US20180028470A1 (es)
EP (1) EP3490578A4 (es)
JP (1) JP2019523264A (es)
KR (1) KR20190032494A (es)
AU (1) AU2017301645A1 (es)
CA (1) CA3032149A1 (es)
MX (1) MX2019000977A (es)
WO (1) WO2018022378A1 (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3946407A4 (en) * 2019-03-24 2022-12-28 Patel, Naishadhkumar Ramubhai Formulation to enhance the bioavailibity and stability of curcuminoids and/or its derivatives thereof

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7968115B2 (en) * 2004-03-05 2011-06-28 Board Of Regents, The University Of Texas System Liposomal curcumin for treatment of cancer
CN100486567C (zh) * 2004-08-12 2009-05-13 山东绿叶天然药物研究开发有限公司 姜黄素乳剂及其制备方法
CN1895239B (zh) * 2006-06-20 2010-05-12 中国人民解放军第二军医大学 一种姜黄素制剂及其制备方法
CN101147727A (zh) * 2006-09-19 2008-03-26 大百汇生物科技（深圳）有限公司 莪术醇亚微乳及其制备方法和制剂
US8383865B2 (en) * 2007-04-17 2013-02-26 Codman & Shurtleff, Inc. Curcumin derivatives
CN102626384A (zh) * 2012-04-12 2012-08-08 临沂大学 一种姜黄素混悬剂及其制备方法
WO2014025672A1 (en) * 2012-08-04 2014-02-13 Eric Hauser Kuhrts Water-soluble lipophilic natural compound formulations

Also Published As

Publication number Publication date
WO2018022378A1 (en) 2018-02-01
CA3032149A1 (en) 2018-02-01
AU2017301645A1 (en) 2019-02-07
EP3490578A1 (en) 2019-06-05
KR20190032494A (ko) 2019-03-27
JP2019523264A (ja) 2019-08-22
EP3490578A4 (en) 2020-02-26
US20180028470A1 (en) 2018-02-01

Similar Documents

Publication Publication Date Title
SG11202105850YA (en) Diphenyl-like compound, intermediate thereof, preparation method therefor, pharmaceutical composition thereof and uses thereof
EP3481402A4 (en) CONNECTIONS, COMPOSITIONS AND METHODS FOR TREATING A DISEASE
MY191581A (en) Anti-pd-1 antibodies
EP3615659A4 (en) COMPOSITIONS AND METHODS OF ENCAPSULATION AND SCALABLE DELIVERY OF AGROCHEMICALS
EP3675859A4 (en) COMPOUNDS, COMPOSITIONS AND METHODS FOR THE TREATMENT OF A DISEASE
EP3484504A4 (en) COMPOUNDS, COMPOSITIONS AND METHODS OF TREATMENT OF DISEASE
SG10201803042PA (en) Anti-tim-3 antibodies
PH12019501872A1 (en) Anti-tryptase antibodies, compositions thereof, and uses thereof
MX367669B (es) Compuestos antiproliferativos y sus composiciones farmacéuticas y usos.
AU2018302170A1 (en) Pharmaceutical compositions comprising entrectinib
EP4339192A3 (en) Compounds and compositions for the treatment of cancer
EP4268896A3 (en) Dosing regimens for treatment of fungal infections
EP3647313A4 (en) SUBSTITUTED ARYLETHER COMPOUND, PROCESS FOR PREPARATION, PHARMACEUTICAL COMPOSITION AND USE
EA201791716A1 (ru) Фармацевтический состав
EP3284743A4 (en) Heterocyclic-imidazole compounds, pharmaceutical compositions thereof, preparation method therefor and use thereof
IN2014CH00840A (es)
HK1250911A1 (zh) 微凝胶颗粒
EP3720844A4 (en) MEDICINAL COMPOSITIONS
PH12017502148A1 (en) Pharmaceutical compositions and use thereof
EP4582145A3 (en) Solid state forms of ixazomib citrate
MA39877A (fr) Formes solides d'un composé pharmaceutiquement actif
EP3496714A4 (en) DRUG COMPOSITIONS.
WO2017161344A8 (en) Compositions and methods for treating parasitic diseases
WO2016069542A3 (en) Lactone compounds and methods of making and using same
MA40027A (fr) Composition pharmaceutique comprenant un bêta-2 agoniste et un agent anticholinergique